Wnt-1 and Wnt-3a exhibit redundancy in neural crest development. We have found that they do not produce the same effects on PC12 cells, which were obtained from the adrenal medulla, a neural crest derivative. However, both Wnt-1 or Wnt-3a inhibit nerve growth factor (NGF)-induced neurite outgrowth. The inhibition is reversed by the protein kinase C (PKC) inhibitor, bisindolylmaleimide-I, but it did not reverse Wnt-1-induced activation of the canonical Wnt pathway. The Wnt-1 inhibitory effect was not reversed by several other PKC inhibitors, by phorbol ester-induced down-regulation of PKC, or by pertussis toxin, which is known to inhibit another Wnt signaling pathway, the Wnt/Ca 2+ pathway. We suggest that bisindolylmaleimide-I acts by affecting either a pathway downstream from Lef-1/Tcf in the canonical pathway or a Wnt signaling pathway other than the canonical pathway. In either case, the bisindolylmaleimide-I sensitivity of this pathway should aid in its identification.
Introduction
Wnt signaling is initiated by binding of the Wnt proteins to their receptors called frizzled (FZ) (Cadigan and Nusse, 1997) . Two major signaling pathways have been described for Wnt-1, the best characterized Wnt. The canonical Wnt pathway involves activation of dishevelled, thereby promoting inactivation of glycogen synthase kinase 3-b (GSK3-b). Inactivation of GSK3-b in turn results in decreased phosphorylation and thus increased stability of b-catenin. As b-catenin levels increase, more b-catenin enters the nucleus allowing its interaction with Lef-1/Tcf transcription factors and subsequent altered gene expression (Cadigan and Nusse, 1997; Tetsu and McCormick, 1999) . Activated dishevelled can also signal through Rho GTPase and Jun N-terminal kinase (JNK) instead of b-catenin and Lef-1/Tcf (Li et al., 1999) .
A second major mechanism of Wnt signaling involves a G protein-mediated activation of a phosphoinositol pathway resulting in increased activities of Ca 2+ -activated enzymes, e.g. protein kinase C (PKC) (Slusarski et al., 1997a,b) .
In mammals, both Wnt-1 and Wnt-3a are expressed in the neural tube during development and they may be functionally redundant (Ikeya et al., 1997) . A deficiency of Wnt-1, by itself, results in the malformation of midbrain and cerebellum (McMahon and Bradley, 1990; Thomas and Capecchi, 1990) whereas the lack of Wnt-3a causes the malformation of paraxial mesoderm (Takada et al., 1994; Yoshikawa et al., 1997) . When both Wnt-1 and Wnt-3a are absent during development, there is a marked deficiency in neural crest derivatives and a reduction in dorsolateral neural precursors within the neural tube (Ikeya et al., 1997) .
Because Wnt-1 and Wnt-3a exhibit redundancy in neural crest development, in this paper we have asked whether they produce the same effects on PC12 cells, which were obtained from the adrenal medulla, a neural crest derivative (Greene and Tischler, 1976) . Some effects of Wnt-1 on PC12 have been characterized previously. PC12 cells that constitutively and ectopically express Wnt-1, hereafter called PC12/Wnt-1 cells, fail to differentiate into neurons in the presence of nerve growth factor (NGF) in spite of exhibiting functional NGF receptors (Shackleford et al., 1993) . PC12/Wnt-1 cells also exhibit a flattened morphology and altered gene expression, and these changes are also exhibited by spontaneously occurring PC12 flattened cell variants that do not express Wnt-1. For example, both PC12 derivatives exhibit an up-regulation of FZ2 expression and down-regulation of FZ5 expression . Furthermore, unlike wild type cells, they both express Wnt-7b and the GLAST glutamate transporter, and they exhibit transporter-mediated glutamate uptake (Ramachandran et al., 1993; Edreich-Epstein and Shackleford, 1998) . We report that Wnt-3a-expressing PC12 cells (PC12/Wnt-3a) are like PC12/Wnt-1 in that NGF-induced neurite outgrowth is inhibited but differ in not exhibiting a flattened morphology, transporter-mediated glutamate uptake, or increased proliferation rate.
The inhibition of NGF-induced differentiation in PC12/Wnt-1 cells is a direct effect of Wnt-1 expression as was shown with PC12 twnt cells, in which Wnt-1 expression levels was controlled by use of a tetracycline-responsive transactivator . Induction of Wnt-1 expression by tetracycline withdrawal was followed by reversible inhibition of NGFinduced neurite outgrowth. Wnt-1 decreased the NGFinduced expression of the late-response gene SCG10 but not of several immediate early genes nor of the late-response genes GAP-43 and collagenase. The twnt cells multiplied at a greater rate when they expressed Wnt-1 than they did in the absence of Wnt-1 expression, consistent with the mitogenic property of Wnt-1 . Wnt-1 expression by the twnt cells resulted in activation of the canonical Wnt signaling pathway as shown by activation of the Lef-1/ Tcf transcription factor . However, the twnt cells express FZ2 , which can also activate the Wnt/Ca 2+ pathway (Slusarski et al., 1997a) . Thus, this pathway could be involved in the inhibition by Wnt-1 of NGF-induced neurite outgrowth in these cells. We have assessed this possibility by use of several PKC inhibitors and other agents. We report that only one of these agents, bisindolylmaleimide-I, reverses the blocking effect of both Wnt-1 and Wnt-3a suggesting that a novel pathway is involved in this effect. We also report that other properties of PC12/Wnt-1 cells are not due to altered expression of FZ or Wnt-7b.
Results
Properties of PC12/Wnt-7b and PC12/Wnt-3a cells
The RT -PCR results of Figure 1a confirm that Wnt7b is expressed by PC12/Wnt-1, but not in wild type PC12. Nor is it expressed by either of two different twnt clones, twnt3-C10 and twnt3 -4, whether or not they expressed Wnt-1, i.e., whether or not tetracycline was present in the medium. We examined whether PC12 cells constitutively expressing Wnt-7b or Wnt-3a would exhibit the properties of PC12 cells constitutively expressing Wnt-1. PC12 cells were stably transfected with an expression vector carrying mouse Wnt-7b or Wnt-3a, and the transfected cells were called PC12/Wnt-7b and PC12/Wnt-3a, respectively. As a control in one case, PC12 stably transfected with the vector alone was prepared and called PC12/vector. As shown in Figure 1a and the Northern blot of Figure  1b , high levels of mRNA for Wnt-7b was found in PC12/Wnt-7b cells. The same was true for Wnt-3a mRNA in PC12/Wnt-3a cells, but not in PC12/vector cells (Figure 1b) . In contrast to PC12/Wnt-1, which has a flattened morphology, both PC12/Wnt-7b and PC12/ Wnt-3a cells are spherical in shape like wild type PC12 (shown for PC12/Wnt-7b in Figure 2a ). After exposure to NGF PC12/Wnt-7b cells extended neurites whereas PC12/Wnt-3a cells flattened, but few extended neurites (Figure 2b,c) .
PC12/Wnt-3a exhibited an increased level of FZ2 expression (Figure 3a) . However, unlike PC12/Wnt-1, PC12/Wnt-7b did not exhibit up-regulation of FZ2 or down-regulation of FZ5 mRNA (Figure 3b ). Neither PC12/Wnt-3a nor PC12/Wnt-7b exhibited transportermediated glutamate uptake (not shown), which was The cells were incubated with NGF (30 ng/ml) for 6 days. (d) 1 mM bisindolylmaleimide-I (Bis) was also present measured as described (Ramachandran et al., 1993) . PC12/Wnt-3a cells multiplied at the same rate as wild type PC12 cells (not shown) and thereby differed from twnt cells, which were found to multiply when Wnt-1 was expressed at more than twice the rate of wild type cells .
Effect of altered FZ expression on wild type PC12 and on a flattened PC12 variant, 2068
We examined whether the flattened morphology of PC12/Wnt-1H and 2068 cells and/or their inability to extend neurites upon exposure to NGF could be due to a lack of FZ5 expression, itself, or to an increased expression of FZ2, itself. By stable transfection with an expression vector carrying FZ2 or FZ5, we prepared a wild type PC12 derivative, PC12/FZ2, that overexpresses FZ2 and a 2068 derivative, 2068/FZ5, that expresses FZ5. The level of FZ mRNA in these cells was assessed by RT -PCR or Northern blotting. The results are shown in Figure 3c ,d. By the RT -PCR criterion, FZ2 mRNA levels were higher in PC12/FZ2 cells than in wild type PC12 cells, and 2068/FZ5 cells did express FZ5. Nevertheless, the PC12/FZ2 cells had a wild type spherical morphology and extended neurites when exposed to NGF (not shown). The 2068/FZ5 cells had a flattened morphology like 2068 cells and did not extend neurites when exposed to NGF (not shown). These results strongly indicate that the differences between wild type PC12 cells and the flattened variants, including those that express Wnt-1 constitutively, are not due to altered FZ expression alone.
Effects of PKC inhibitors or a phorbol ester
The twnt cells were used to examine whether a PKC was involved in the inhibition by Wnt-1 of NGFinduced differentiation. Figure 4 shows the effect of the PKC inhibitor bisindolylmaleimide-I (Toullec et al., 1991) on NGF-induced neurite outgrowth from twnt3-C10 cells after a 6-day exposure to NGF. These cells were cultured in tetracycline-free medium to allow Wnt 1 expression, or they were cultured in medium containing tetracycline at 0.1 mg/ml to prevent Wnt-1 expression. There was no extension of neurites from the twnt3-C10 cells in the absence of NGF. Less than 5% of the NGF-treated twnt3-C10 cells extended neurites of length greater than two cell diameters when Wnt-1 was expressed in the cells. Under these conditions the twnt3-C10 cells continued to multiply and cluster as reported previously . However, bisindolylmaleimide-I at 1 mM reversed the inhibition by Wnt-1 of NGF-induced neurites. When plasmid template was used in the indicated amounts to estimate the level of FZ2 cDNA formed by reverse transcription of cellular FZ2 mRNA. As a control for RNA integrity during the RT -PCR, primers amplifying glyceraldehyde phosphate dehydrogenase (GAPDH) were also used. CHOB was probed (b) or 28S and 18S RNA was used (d) as a loading control for the Northern blots bisindolylmaleimide-I was present, 84% of the NGFtreated cells extended neurites of length greater than two cell diameters. These neurites were comparable to those formed from NGF-treated wild type PC12 cells. A repeat experiment gave similar results. Bisindolylmaleimide-I, by itself, did not induce neurites from the twnt3-C10 cells or from wild type PC12 cells. When tetracycline was present so Wnt-1 was not expressed, 66 -73% of the NGF-treated twnt3-C10 cells extended normal neurites whether bisindolylmaleimide-I was present or not. Bisindolylmaleimide-I also reversed the inhibition by Wnt-1 of NGF-induced neurite outgrowth from twnt3 -4 cells, and it had no effect on NGF-induced neurite outgrowth from wild type PC12 cells (not shown).
Bisindolylmaleimide-I at 1 mM also reversed the inhibition of NGF-induced neurite outgrowth in PC12/Wnt-3a cells (Figure 2d ). Only 11% of PC12/ Wnt-3a cells treated for 6 days with NGF alone extended neurites of length greater than two cell body diameters. However, if bisindolylmaleimide-I was also present during the NGF treatment, 72% of PC12/Wnt3a cells extended neurites of length greater than two cell body diameters. A repeat experiment yielded similar results. Using the same protocol described for Figure 4 we have found that none of several other known inhibitors of protein kinase C (Way et al., 2000) reversed the inhibition by Wnt-1 of NGF-induced neurite outgrowth from twnt3-C10 cells (data not shown). The inhibitors used were H7 (10 mM), staurosporine (0.2 mM), Go 6983 (1 mM), Ro31-8220 (5 mM), and rottlerin (5 mM).
We also measured neurite outgrowth from Wnt-1-expressing twnt 3-C10 cells that had been chronically exposed to the phorbol ester 4-a-phorbol 12 myristate 13-acetate (TPA) at a dose known to down-regulate several PKC isozymes in many cells (Adams and Gullick, 1989) . The cells were pretreated for 48 h with 800 nM TPA, or with vehicle (DMSO) as a control, and then for 6 days with NGF as described for Figure 4 but in the presence of TPA or DMSO. The number of neurites exhibited by cells treated with NGF and TPA was no greater than those treated with NGF and vehicle or with NGF without TPA or vehicle. Under the conditions used, phorbol esters by themselves do not inhibit NGF-induced neurite outgrowth from PC12 cells (Burstein et al., 1982) , a finding we have confirmed by treating twnt 3-C10 cells with NGF in the presence of TPA and tetracycline so Wnt-1 was not expressed.
Effect of bisindolylmaleimide-I and other compounds on the inhibition by Wnt-1 of NGF induced up-regulation of SCG10
The NGF-induced levels of SCG10 and GAP43 proteins in twnt3-C10 or twnt3 -4 cells treated with or without bisindolylmaleimide-I are shown in Figure  5 . When bisindolylmaleimide-I was present, SCG10 was induced to a near normal level by NGF even though Wnt-1 was expressed. Bisindolylmaleimide-I, by itself, did not increase SCG10 levels in cells not exposed to NGF, nor did bisindolylmaleimide-I further increase the NGF-induced levels of SCG10 cells when Wnt-1 was not expressed. Bisindolylmaleimide-I, under any condition, did not affect the level of GAP43, whose induction by NGF is not inhibited by Wnt-1 as was shown previously (Chou et al., 2000) . Figure 4 Effect of bisindolylmaleimide-I on NGF-induced neurite outgrowth from twnt3-C10 cells. The cells were incubated with NGF (30 ng/ml) for 6 days. Wnt-1 expression was repressed in two cases by the inclusion of tetracycline (0.1 mg/ml), and the other two cases Wnt-1 expression was induced by culturing the cells in tetracycline-free medium. Where indicated, 1 mM bisindolylmaleimide-I (Bis) was also present Figure 5 Effect of bisindolylmaleimide-I on the NGF-induced expression of SCG10 and GAP43 in twnt3 -C10 cells and twnt3 -4 cells. The cells were incubated in the absence or presence of NGF (30 ng/ml) for 24 h. As indicated, Wnt-1 expression was either repressed by the inclusion of tetracycline (0.1 mg/ml), or induced by culturing the cells in tetracycline-free medium. Bisindolylmaleimide-I (Bis) at 1 mM was also present as indicated. After 24 h, protein was isolated, and subjected to SDS -PAGE and Western blotting using anti-SCG10 and anti-GAP43 antibodies as described Using the same procedure described for Figure 5 , we also examined whether 20 mM myo-inositol, 0.2 mM staurosporine, or 10 mM H7 could stimulate or reverse the inhibition by Wnt-1 of NGF induced SCG10 upregulation. Myo-inositol inhibits GSK3-b activity and thus activates the downstream portion of the canonical Wnt pathway (Hedgepeth et al., 1997) . However, none of these compounds altered the level of induction of SCG10 by NGF when Wnt-1 was not expressed or affected the ability of Wnt-1 to inhibit the NGFinduced up-regulation of SCG10 when Wnt-1 was expressed (data not shown).
Effect of bisindolylmaleimide-I on Wnt-1-induced Lef-1/Tcf activity
We examined whether the ability of bisindolylmaleimide-I to reverse the inhibition by Wnt-1 of NGFinduced neurite outgrowth and SCG10 up-regulation was due to an effect on the canonical Wnt signaling pathway. We measured the effect of bisindolylmaleimide-I on Wnt-1-induced activity of the Lef-1/Tcf transcription factor. PC12/Wnt-1H cells were transiently cotransfected with the TopFlash vector and an expression vector carrying the b-galactosidase gene, which was used to assess transfection efficiency. We attempted unsuccessfully to use the TopFlash assay in the PC12/Wnt-3a cells to determine whether Wnt-3a expression in PC12 cells resulted in induction of Lef-1/TCf activity and whether bisindolylmaleimide-I reversed this induction. Luciferase activity was barely detectable and b-galactosidase activity was not detected after cotransfection of PC12/Wnt-3a cells with the bgalactosidase vector and either the TopFlash or FopFlash vector. Thus, the transfection efficiency of the PC12/Wnt-3a was too low for the TopFlash assay.
Effect of pertussis toxin
We also used pertussis toxin to assess the role of the Wnt/Ca 2+ pathway in the inhibition by Wnt-1 of NGF-induced neurite outgrowth. This pathway signals via a pertussis toxin-sensitive G-protein coupled system (Liu et al., 1999) and thus can be inhibited by pertussis toxin. As is shown in Figure 7 , pertussis toxin did not affect the inhibition by Wnt-1 of NGF-induced neurite outgrowth from either twnt3-C10 or twnt-4 cells. The twnt cells were exposed to NGF for 6 days with or without pertussis toxin at 200 ng/ml. When Wnt-1 was expressed in NGF-treated twnt3-C10 cells or twnt3 -4 cells, only 5 -8% of the cells extended neurites whether pertussis toxin was present or not. Pertussis toxin had no effect on neurite outgrowth from twnt3-C10 or twnt3 -4 cells in the cases where Wnt-1 was not expressed. Under this condition, 58 -65%, respectively, of the NGF-treated cells extended neurites in the absence of pertussis toxin, and 72 -74%, respectively, of the cells extended neurites in the presence of pertussis toxin. Similar results were obtained in a repeat experiment. Pertussis toxin also did not affect NGF-induced neurite outgrowth from wild type PC12 Figure 7 The effect of pertussis toxin on the inhibition by Wnt-1 of NGF-induced neurite outgrowth from twnt3-C10 and twnt3 -4 cells. The cells were incubated with NGF (30 ng/ml) for 6 days. Where indicated, pertussis toxin (PT) at 200 ng/ml was also present, and Wnt-1 expression was either induced by culturing the cells in tetracycline-free medium or repressed by the inclusion of tetracycline (0.1 mg/ml) in the medium. Cells were counted as extending neurites if they had neurites of length greater than two cell diameters. At least 225 cells total for each condition were examined cells (not shown). The results of Figure 7 thus indicate that the Wnt/Ca 2+ /pertussis toxin-sensitive pathway is not involved in the inhibition by Wnt-1 of NGFinduced neurite outgrowth.
The pertussis toxin used for the above study was active as shown by its ability to prevent C-type natriuretic peptide from inhibiting K + -induced dopamine release, an effect described by Trachte et al. (1995) . We pretreated wild type PC12 cells for 18 h in the presence or absence of pertussis toxin at 100 ng/ml, allowed the cells to take up [ 3 H]dopamine, and the extent of release of the previously accumulated [ 3 H]dopamine upon exposure to 56 mM K + was measured as described (Bitler et al., 1986) in the presence or absence of 100 nM C-type natriuretic peptide. Quadruplicate samples of cells were incubated for each condition. Control cells released 46+3% of their [
3 H]dopamine content upon exposure to 56 mM K + whereas cells exposed only to C-type natriuretic peptide released 29+1% of their [
3 H]dopamine content under these conditions. Cells pretreated with pertussis toxin and then with C-type natriuretic peptide released 49+5% of their [
3 H]dopamine content showing that the pertussis toxin was active.
Wnt-1 does not signal via the Dsh/JNK pathway in twnt cells
Another potential pathway for Wnt-1 to interact with PKC to affect neurite outgrowth is the Dsh/JNK pathway. We used a specific antibody that detects activated JNK1 and JNK2 to examine the status of the endogenous JNK activity in twnt cells expressing Wnt-1. The Western blot of Figure 8 shows that JNK was not activated in cells expressing Wnt-1. Two commercially supplied positive controls were used for this study. They were protein extracts of 293 and wild type PC12 cells that had been treated, respectively, with ultraviolet light or osmotically shocked with sorbitol, both of which activate JNK (Tokiwa et al., 1996) . A third positive control was a protein extract of sorbitoltreated twnt3 -4 cells. Only JNK1 was activated by the sorbitol treatment in the twnt3 -4 cells. JNK was not activated when either wild type or Wnt-1-expressing twnt cells were exposed to NGF (not shown).
Discussion
Wnt-1 and Wnt-3a both inhibit NGF-induced neurite outgrowth from PC12 cells. However, they do not produce identical effects on PC12 cells; e.g., Wnt-1, but not Wnt-3a, increases the rate of cell proliferation . Our results are consistent with these two Wnts' having functional redundancy in neural crest development (Ikeya et al., 1997) . Interestingly, Ikeya et al. (1997) have suggested that the role of Wnt-1 in neural crest development is to increase the number of certain neural crest progenitor cells by preventing their premature differentiation. Furthermore, they proposed that Wnt-1 acts as a mitogen for these cells.
Intriguingly, bisindolylmaleimide-I reversed the inhibition by Wnt-1 or by Wnt-3a NGF-induced neurite outgrowth and the inhibition by Wnt-1 of NGFinduced SCG10 expression. However bisindolylmaleimide-I did not reverse the activation by Wnt-1 of Lef-1/Tcf, demonstrating that bisindolylmaleimide-I does not affect the canonical Wnt pathway, which is activated when Wnt-1 is expressed in PC12 cells . This result suggests that bisindolylmaleimide-I acts by affecting either a pathway downstream from Lef-1/Tcf in the canonical pathway or a Wnt signaling pathway other than the canonical pathway. In either case, the bisindolylmaleimide-I sensitivity of this pathway should aid in its identification. Our studies with pertussis toxin and anti-activated JNK antibody indicate that neither the Wnt/Ca 2+ nor Dsh/ JNK pathway was involved in the inhibition by Wnt-1 of NGF-induced neurite outgrowth.
Bisindolylmaleimide-I was originally found to be an inhibitor of PKC, but not of several other protein kinases including protein kinase A, myosin light chain kinase, insulin receptor tyrosine kinase or epidermal growth factor tyrosine kinase (Toullec et al., 1991) . However, none of several other PKC inhibitors, H7, staurosporine, Go 6983, R031-8220, nor rottlerin reversed the effect of Wnt-1. We have not directly shown that these other PKC inhibitors were active in our cells. Nevertheless, many other investigators have found that each of these other inhibitors are active in PC12 cell at the same or even lower concentrations used by us (for example, Xie et al., 1995; Ito et al., 1997; Ivins et al., 1999; Zheng et al., 2000; Soltoff, 2001) .
There are 12 different known PKC isozymes (Dempsey et al., 2000) and PC12 expresses at least seven of these PKC isozymes (Borgatti et al., 1996) . twnt3 -4 cells were cultured in tetracycline-free medium to allow Wnt-1 expression. As a positive control, some of these twnt3 -4 cells were exposed for 5 min to 500 mM sorbitol as described in Promega Technical Bulletin number 262 to activate JNK. Other control protein from untreated and UV-treated 293 cells was obtained from Cell Signaling Technology, and protein from sorbitol treated wild type PC12 cells was obtained from Promega (Madison, WI, USA). 20 mg of protein from each of these cells was subjected to SDS -PAGE, and Western blotting using anti-activated JNK antibody was performed according to the protocol recommended by Cell Signaling Technology. A repeat experiment gave similar results Three of the PKC isozymes present in PC12 are known to be inhibited by bisindolylmaleimide-I. However, these same PKC isozymes are also known to be inhibited by one or more of the other PKC inhibitors we found unable to reverse the ability of Wnt-1 or Wnt-3a to inhibit NGF-induced neurite outgrowth (Toullec et al., 1991; Way et al., 2000) . Furthermore, taken together, these other PKC inhibitors are effective against more of the known PKC isozymes than is bisindolylmaleimide-I (Way et al., 2000) .
Wingless is the Drosophila Wnt-1 homolog. Cook et al. (1996) proposed a role for PKC in the canonical Wnt pathway based on their finding that both R031-8220 and chronic treatment with TPA decreased the ability of wingless to inhibit GSK3-b. Our results are quite different in that neither R031-8220 nor chronic treatment with TPA affected the inhibition by Wnt-1 of NGF-induced neurite outgrowth. Two possibilities can account for these results along with the failure of other PKC inhibitors to mimic the effect of bisindolylmaleimide-I. First it may be that bisindolylmaleimide-I acts in the PC12 system by inhibiting a PKC that is not inhibited by any of the other compounds tested and that is not down-regulated by TPA. Although R031-8220 (bisindolylmaleimide-IX) is structurally related to bisindolylmaleimide-I, it does have a different specificity for PKC isozymes (Way et al., 2000) . The second possibility is that bisindolylmaleimide-I affects the Wnt signaling pathway by an action on a protein other than PKC. Recently, bisindolylmaleimide-I was reported also to inhibit GSK-b (Hers et al., 1999) . However, such inhibition should result in its mimicking the effect of Wnt-1, not reversing that effect as was found in our experiments. Furthermore, we found that exposure to myo-inositol, which also inhibits GSK3-b activity and activates the downstream portion of the canonical Wnt pathway (Hedgepeth et al., 1997) , did not block NGF-induced SCG10 expression when Wnt-1 was not expressed.
Materials and methods

Chemicals and cDNA constructs
Bisindolylmaleimide-I (GF109203X), bisindolylmaleimide-IX (Ro31-8220), staurosporine, H7, rottlerin, myo-inositol, pertussis toxin, and C-type natriuretic peptide were purchased from Sigma (St. Louis, MO, USA) and Go 6983 from Calbiochem (San Diego, CA, USA). cDNAs of mouse Wnt-3a and Wnt-7b, human FZ5, and full rat FZ2 were kind gifts from respectively, Drs Tim Lane (University of California, Los Angeles), Jeremy Nathans (Johns Hopkins University, Baltimore, MD, USA), and Robert Nissenson (University of California, San Francisco, CA, USA). Each of these vectors was cloned into the pCDNA3-neomycin vector.
Antibodies
Anti-SCG10 antibody was a gift from Dr Gabriele Grenningloh, Institut de Biologie Cellulaire et de Morphologie, Switzerland, anti-GAP-43 antibody was purchased from Boehringer Mannheim (Indianapolis, IN, USA) , and antiactivated JNK antibody was purchased from Cell Signaling Technology (Beverly, MA, USA).
Cells and media
Wild type and variant PC12 cells were cultured as described . 2068 is a clone of a spontaneously occurring PC12 flattened cell variant. PC12/Wnt-1H are PC12 cells that carry and constitutively express the Wnt-1 gene, and twnt3-C10 and twnt3 -4 are clones of PC12 cells that express Wnt-1 under control of a tetracycline regulated transactivator .
Reverse transcription-polymerase chain reaction and Northern blotting cDNA was generated from total RNA (5 mg) and amplified by PCR using the following primers purchased from Operon Technologies (Alameda, CA): rat FZ2 (sense) 5'-CGTAC-CGGCCACCATCGTCAT-3' and (anti-sense) 5'-CACGGT-TGCAGTCCGGACCTG-3'; GAPDH (sense) 5'-ACCACA-GTCCATGCCATCAC-3' and (antisense) 5'-TCCACCACC-CTGTTGCTGTA-3'. Northern blotting was performed as described .
TopFlash/FopFlash assay for Lef-1/Tcf activity
The TopFlash/FopFlash assay for Lef-1/Tcf activity was performed as described by Korinek et al. (1997) with the variations described by Chou et al. (2000) . b-galactosidase was assayed as described (Sambrook et al., 1989) .
Neurite extension assay
Mouse 2.5s NGF (Upstate Biotechnology, Lake Placid, NY, USA) was added at 30 ng/ml to cells in culture, and medium was changed every 3 days. When quantifying the effect of NGF, we examined all of the cells in each of 10 randomly chosen microscopic fields. At least 225 cells total for each condition were examined. A cell was considered to respond to NGF if it extended neurites of at least two cell bodies in length after the incubation duration indicated.
